Professor Michael Gait is Programme Leader at the Medical Research Council. His laboratory of Molecular biology in Cambridge is working on PNA and PMO oligonucleotides as therapeutics for exon skipping in Duchenne muscular dystrophy.

He is a Fellow of the Royal Society of Chemistry. Mike Gait is currently working in collaboration with Professor Matthew Wood at Oxford University on new treatments for Duchenne muscular dystrophy.